Home / About Us
About us
An early stage company developing a novel therapy for the treatment of epilepsy, built inside InCube Labs.
A company built inside a lab
Neurolink is an early stage company developing a novel therapy for the treatment of epilepsy.
The approach and technology for Neurolink was developed at InCube Labs, a multi-disciplinary life sciences R&D lab focused on developing breakthrough medical innovations.
InCube is led by Mir Imran, a prolific medical inventor, entrepreneur and investor — and Neurolink’s chairman.
- CompanyNeurolink, Inc.
- StageEarly stage — pre-clinical studies
- FocusA drug-device combination therapy for epilepsy
- OriginDeveloped at InCube Labs
- Location12500 Network Blvd. Ste. 112, San Antonio, TX 78249
The Neurolink therapy delivers a powerful pharmacologic agent to the brain in small quantities through the implanted device.
Why InCube matters
InCube Labs launches companies around medical devices and combination products; Neurolink is one of them, and shares the lab’s San Antonio operation with its president, Phil Morgan.
That is the whole of the public record: an early stage company, a technology, a team, and a contact address. What the record contains.